GGD6 (Azithromycin monohydrate 250 mg)
Pill imprint GGD6 has been identified as Azithromycin monohydrate 250 mg.
Azithromycin is used in the treatment of chlamydia infection; bacterial infection; bronchitis; upper respiratory tract infection; std prophylaxis (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Azithromycin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 250 mg
- 15.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|63739-0575||McKesson Packaging Services|
Note: Inactive ingredients may vary.
More about azithromycin
- Azithromycin extended-release oral suspension
- Azithromycin oral suspension
- Azithromycin single-dose packet
- Azithromycin tablets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.